Bae I - Search Results

1

Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer.

Hong YB, Kim JS, Yi YW, Seong YS, Bae I. Hong YB, et al. Among authors: bae i. Pancreas. 2012 Apr;41(3):496-8. doi: 10.1097/MPA.0b013e318230f71a. Pancreas. 2012. PMID: 22415672 Free PMC article. No abstract available.

2

Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer.

Kim YJ, Hong YB, Cho CH, Seong YS, Bae I. Kim YJ, et al. Among authors: bae i. Pancreas. 2012 Jul;41(5):804-5. doi: 10.1097/MPA.0b013e31823f3fcb. Pancreas. 2012. PMID: 22695089 Free PMC article. No abstract available.

3

Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH, Lee JM, Kallakury BV, Bae I. Hong YB, et al. Among authors: bae i. Pancreas. 2010 May;39(4):463-72. doi: 10.1097/MPA.0b013e3181c31314. Pancreas. 2010. PMID: 20118824 Free PMC article.

4

Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine.

Kim YJ, Hwang JS, Hong YB, Bae I, Seong YS. Kim YJ, et al. Among authors: bae i. Anticancer Res. 2012 Mar;32(3):799-806. Anticancer Res. 2012. PMID: 22399597 Free PMC article.

5

Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.

Duong HQ, Hong YB, Kim JS, Lee HS, Yi YW, Kim YJ, Wang A, Zhao W, Cho CH, Seong YS, Bae I. Duong HQ, et al. Among authors: bae i. J Cell Mol Med. 2013 Oct;17(10):1261-70. doi: 10.1111/jcmm.12101. Epub 2013 Jul 16. J Cell Mol Med. 2013. PMID: 23855452 Free PMC article.

6

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.

Duong HQ, Yi YW, Kang HJ, Hong YB, Tang W, Wang A, Seong YS, Bae I. Duong HQ, et al. Among authors: bae i. Int J Oncol. 2014 Mar;44(3):959-69. doi: 10.3892/ijo.2013.2229. Epub 2013 Dec 23. Int J Oncol. 2014. PMID: 24366069 Free PMC article.

7

Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.

Duong HQ, Yi YW, Kang HJ, Bae I, Jang YJ, Kwak SJ, Seong YS. Duong HQ, et al. Among authors: bae i. Int J Oncol. 2014 Jun;44(6):2132-8. doi: 10.3892/ijo.2014.2357. Epub 2014 Mar 21. Int J Oncol. 2014. PMID: 24676703 Free PMC article.

8

ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine.

Duong HQ, Kim HJ, Kang HJ, Seong YS, Bae I. Duong HQ, et al. Among authors: bae i. Oncol Rep. 2012 Jan;27(1):182-8. doi: 10.3892/or.2011.1503. Epub 2011 Oct 12. Oncol Rep. 2012. PMID: 21993922 Free PMC article.

9

Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.

Duong HQ, Hwang JS, Kim HJ, Kang HJ, Seong YS, Bae I. Duong HQ, et al. Among authors: bae i. Int J Oncol. 2012 Sep;41(3):855-61. doi: 10.3892/ijo.2012.1516. Epub 2012 Jun 12. Int J Oncol. 2012. PMID: 22710732 Free PMC article.

10

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells.

Yi YW, Hong W, Kang HJ, Kim HJ, Zhao W, Wang A, Seong YS, Bae I. Yi YW, et al. Among authors: bae i. J Cell Mol Med. 2013 May;17(5):648-56. doi: 10.1111/jcmm.12046. Epub 2013 Apr 20. J Cell Mol Med. 2013. PMID: 23601074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters